Preparation of Dolutegravir Intermediate Diastereomer
- 6 June 2019
- journal article
- research article
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 56 (7) , 2063-2067
Abstract
A convenient method was developed to prepare the diastereomer of dolutegravir tricyclic intermediate in the catalysis of EDCI/DMAP in up to 87% yield. Different solvents, temperature, and times were optimized. The synthesized diastereomer 6′ could be used as a standard for the industrial manufacture requirement of dolutegravir active pharmaceutical ingredient.Keywords
This publication has 8 references indexed in Scilit:
- Structure Based Drug Design: Clinically Relevant HIV-1 Integrase InhibitorsCurrent Topics in Medicinal Chemistry, 2019
- 7‐Step Flow Synthesis of the HIV Integrase Inhibitor DolutegravirAngewandte Chemie International Edition, 2018
- Structure-Guided Optimization of HIV Integrase Strand Transfer InhibitorsJournal of Medicinal Chemistry, 2017
- The inhibition process of HIV-1 integrase by diketoacids molecules: Understanding the factors governing the better efficiency of dolutegravirBiochemical and Biophysical Research Communications, 2017
- Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1AIDS, 2015
- Pharmacokinetics of Dolutegravir in a Premature Neonate after HIV Treatment Intensification during PregnancyAntimicrobial Agents and Chemotherapy, 2015
- Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)Journal of Medicinal Chemistry, 2013
- Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic ProfilesJournal of Medicinal Chemistry, 2013